Provided by Tiger Trade Technology Pte. Ltd.

JW THERAP-B

1.960
+0.0753.98%
Volume:678.50K
Turnover:1.29M
Market Cap:817.32M
PE:-1.25
High:1.965
Open:1.910
Low:1.805
Close:1.885
52wk High:6.190
52wk Low:1.400
Shares:417.00M
HK Float Shares:417.00M
Volume Ratio:0.91
T/O Rate:0.16%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.564
ROE:-64.37%
ROA:-11.43%
PB:1.26
PE(LYR):-1.25
PS:2.47

Loading ...

Company Profile

Company Name:
JW THERAP-B
Exchange:
SEHK
Establishment Date:
2016
Employees:
314
Office Location:
Building B,5th Floor,No. 699 Zhong Ke Road,Pudong New District,Shanghai,China
Website:
- -
Zip Code:
- -
Fax:
- -
Introduction:
JW (Cayman) Therapeutics Co Ltd is a company primarily engaged in research and development, manufacturing, and marketing of cellular immunotherapy products. The Company has built an integrated platform for product development in cell immunotherapy, as well as a product pipeline covering hematologic malignancies, solid tumors and autoimmune diseases. The Company’s main product, Carteyva, is an autologous anti-CD19 chimeric antigen receptor T-cell (CAR-T) cell immunotherapy product independently developed by the Company based on a CAR-T cell process platform of Juno (a Bristol Myers Squibb company). The Company mainly conducts its business in the domestic market.

Directors

Name
Position
TIAN Feng
Chairman of the Board,Executive Director,Member of the Strategic and Development Committee,Member of the Nomination Committee
GAO Xing
Director,Member of the Strategic and Development Committee,Audit Committee Member
LI Yi Ping
Director
HE Jian Chang
Independent Director,Chairman of the Nomination Committee,Audit Committee Chairman
Debra Yu
Independent Director,Chairman of the Strategic and Development Committee,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee
CHEN Bing Jun
Independent Director,Member of the Remuneration and Assessment Committee,Audit Committee Member

Shareholders

Name
Position
TIAN Feng
CEO
LIN Ping
CEO,CFO
TU Zhi Dan
Vice General Manager
WU Jia Wen
Corporate Secretary
HE Shu Yang
Chief Science Officer
JIANG Yi Zhang
Other Senior Executives,Other Senior Executives